GL1X · GenesisL1 explorer

Research workbench

Structure of the clinically used myxomaviral serine protease inhibitor 1 (serp-1)

Analyse Structure of the clinically used myxomaviral serine protease inhibitor 1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BJ5
Type
protein
Length
990 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serine proteinase inhibitor 1
UniProt
P12393
Ligands
P15, NAG
Pockets
10 · best druggability 0.72

Structure

x-ray diffraction · 6 distinct chains · 23% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BSerine proteinase inhibitor 1protein29326% helix, 35% strandP12393
FSerine proteinase inhibitor 1protein380% helix, 58% strandP12393
ASerine proteinase inhibitor 1protein29226% helix, 38% strandP12393
GSerine proteinase inhibitor 1protein390% helix, 54% strandP12393
CSerine proteinase inhibitor 1protein28827% helix, 36% strandP12393
HSerine proteinase inhibitor 1protein400% helix, 53% strandP12393

Ligands and binding sites

  • P15 · 2,5,8,11,14,17-hexaoxanonadecan-19-ol · ligand · chains C, H
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains B, C, A, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18710.720.7771empty
27710.690.7649empty
34790.640.7747empty
43460.640.7952empty
52110.530.7721empty

Interfaces

9 interfaces between chains.

  • C–H · 2399 Ų buried · 41 hydrogen bonds · protein-protein
  • A–G · 2397 Ų buried · 32 hydrogen bonds · protein-protein
  • B–F · 2372 Ų buried · 37 hydrogen bonds · protein-protein
  • B–A · 518 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 385 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 glycan (N-glycosylation).

Compared structures

  • 6BJ5 · Structure of the Clinically used Myxomaviral Serine Protease Inhibitor 1 (SERP-1) · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.